<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cross AJ</submitter><funding>National Health and Medical Research Council</funding><funding>Medical Research Future Fund</funding><pagination>e70141</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12945874</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>45(1)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>High-risk medications are medications associated with significant patient harm or death if misused or used in error. This study aimed to develop a national consensus high-risk medication list for use in Australian residential aged care.&lt;h4>Methods&lt;/h4>A 3-round modified Delphi study involving Australian healthcare professionals was conducted. In Round 1, participants indicated their level of agreement, on a 9-point Likert scale, whether 60 medications/medication classes were considered high-risk and should be included in a high-risk medication list for Australian residential aged care. Round 2 included medications/medication classes that did not reach consensus and new medications identified by participants. Consensus was defined as 70% or more of participants respondi</pubmed_abstract><journal>Australasian journal on ageing</journal><pubmed_title>Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi Study.</pubmed_title><pmcid>PMC12945874</pmcid><funding_grant_id>PHRDI000008</funding_grant_id><funding_grant_id>APP2009633</funding_grant_id><pubmed_authors>Lord L</pubmed_authors><pubmed_authors>Turner JP</pubmed_authors><pubmed_authors>Cross AJ</pubmed_authors><pubmed_authors>Manek A</pubmed_authors><pubmed_authors>Liew DFL</pubmed_authors><pubmed_authors>Rawson H</pubmed_authors><pubmed_authors>Clark M</pubmed_authors><pubmed_authors>Macfarlane S</pubmed_authors><pubmed_authors>Steeper M</pubmed_authors><pubmed_authors>Lee K</pubmed_authors><pubmed_authors>Godbole GP</pubmed_authors><pubmed_authors>McInerney B</pubmed_authors><pubmed_authors>Daly S</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Marinucci A</pubmed_authors><pubmed_authors>Hart B</pubmed_authors><pubmed_authors>Pond CD</pubmed_authors><pubmed_authors>Chaudhry M</pubmed_authors><pubmed_authors>Hawthorne D</pubmed_authors><pubmed_authors>Slatyer S</pubmed_authors><pubmed_authors>Wasef K</pubmed_authors><pubmed_authors>Manias E</pubmed_authors><pubmed_authors>Breen JL</pubmed_authors><pubmed_authors>Hayball PJ</pubmed_authors><pubmed_authors>Kulh M</pubmed_authors><pubmed_authors>Delardes B</pubmed_authors><pubmed_authors>Goordeen D</pubmed_authors><pubmed_authors>Hilmer SN</pubmed_authors><pubmed_authors>Andrew NE</pubmed_authors><pubmed_authors>Kouladjian O'Donnell L</pubmed_authors><pubmed_authors>Thomson AB</pubmed_authors><pubmed_authors>Stafford A</pubmed_authors><pubmed_authors>Zimmerman J</pubmed_authors><pubmed_authors>Bell JS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi Study.</name><description>&lt;h4>Introduction&lt;/h4>High-risk medications are medications associated with significant patient harm or death if misused or used in error. This study aimed to develop a national consensus high-risk medication list for use in Australian residential aged care.&lt;h4>Methods&lt;/h4>A 3-round modified Delphi study involving Australian healthcare professionals was conducted. In Round 1, participants indicated their level of agreement, on a 9-point Likert scale, whether 60 medications/medication classes were considered high-risk and should be included in a high-risk medication list for Australian residential aged care. Round 2 included medications/medication classes that did not reach consensus and new medications identified by participants. Consensus was defined as 70% or more of participants respondi</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-07-16T22:14:57Z</modification><creation>2026-07-12T03:08:37.629Z</creation></dates><accession>S-EPMC12945874</accession><cross_references><pubmed>41748493</pubmed><doi>10.1111/ajag.70141</doi></cross_references></HashMap>